Literature DB >> 23723024

Factors limiting exercise tolerance in chronic lung diseases.

Ioannis Vogiatzis1, Spyros Zakynthinos.   

Abstract

The major limitation to exercise performance in patients with chronic lung diseases is an issue of great importance since identifying the factors that prevent these patients from carrying out activities of daily living provides an important perspective for the choice of the appropriate therapeutic strategy. The factors that limit exercise capacity may be different in patients with different disease entities (i.e., chronic obstructive, restrictive or pulmonary vascular lung disease) or disease severity and ultimately depend on the degree of malfunction or miss coordination between the different physiological systems (i.e., respiratory, cardiovascular and peripheral muscles). This review focuses on patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and pulmonary vascular disease (PVD). ILD and PVD are included because there is sufficient experimental evidence for the factors that limit exercise capacity and because these disorders are representative of restrictive and pulmonary vascular disorders, respectively. A great deal of emphasis is given, however, to causes of exercise intolerance in COPD mainly because of the plethora of research findings that have been published in this area and also because exercise intolerance in COPD has been used as a model for understanding the interactions of different pathophysiologic mechanisms in exercise limitation. As exercise intolerance in COPD is recognized as being multifactorial, the impacts of the following factors on patients' exercise capacity are explored from an integrative physiological perspective: (i) imbalance between the ventilatory capacity and requirement; (ii) imbalance between energy demands and supplies to working respiratory and peripheral muscles; and (iii) peripheral muscle intrinsic dysfunction/weakness.
© 2012 American Physiological Society. Compr Physiol 2:1745-1766, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 23723024     DOI: 10.1002/cphy.c110015

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  16 in total

Review 1.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Efficacy of a simple and inexpensive exercise training program for advanced chronic obstructive pulmonary disease patients in community hospitals.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease.

Authors:  Randall E Keyser; Joshua G Woolstenhulme; Lisa M K Chin; Steven D Nathan; Nargues A Weir; Gerilynn Connors; Bart Drinkard; James Lamberti; Leighton Chan
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 Jan-Feb       Impact factor: 2.081

Review 4.  Healthful aging mediated by inhibition of oxidative stress.

Authors:  Stephen F Vatner; Jie Zhang; Marko Oydanich; Tolga Berkman; Rotem Naftalovich; Dorothy E Vatner
Journal:  Ageing Res Rev       Date:  2020-10-19       Impact factor: 10.895

5.  Reproducibility of NIRS assessment of muscle oxidative capacity in smokers with and without COPD.

Authors:  Alessandra Adami; Robert Cao; Janos Porszasz; Richard Casaburi; Harry B Rossiter
Journal:  Respir Physiol Neurobiol       Date:  2016-09-19       Impact factor: 1.931

6.  Early surgery increases mitochondrial DNA release and lung injury in a model of elderly hip fracture and chronic obstructive pulmonary disease.

Authors:  Jianzheng Zhang; Juan Wang; Xiaowei Wang; Zhi Liu; Jixin Ren; Tiansheng Sun
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

7.  A double blind randomized placebo control crossover trial on the effect of dietary nitrate supplementation on exercise tolerance in stable moderate chronic obstructive pulmonary disease.

Authors:  Paul Leong; Jane E Basham; Theresa Yong; Adrian Chazan; Paul Finlay; Sara Barnes; Phillip G Bardin; Donald Campbell
Journal:  BMC Pulm Med       Date:  2015-05-02       Impact factor: 3.317

Review 8.  Pathogenesis of hyperinflation in chronic obstructive pulmonary disease.

Authors:  Philippe Gagnon; Jordan A Guenette; Daniel Langer; Louis Laviolette; Vincent Mainguy; François Maltais; Fernanda Ribeiro; Didier Saey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-15

9.  Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation.

Authors:  Sébastien Hulo; Jocelyn Inamo; Aurélie Dehon; Olivier Le Rouzic; Jean-Louis Edme; Remi Neviere
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-17

10.  Assessing the Value of BMI and Aerobic Capacity as Surrogate Markers for the Severity of Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Who Are Obese.

Authors:  Cassandra Smith; Muhammad Asrar Ul Haq; George Jerums; Erik Hanson; Alan Hayes; Jason D Allen; Melissa Sbaraglia; Steve Selig; Chiew Wong; David L Hare; Itamar Levinger
Journal:  Clin Med Insights Cardiol       Date:  2016-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.